Live from the NIH registry
Studies recruiting near Reno right now
Top 25 of 195 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer, c-MET
Phase 3
Interventional 768 participants sought
Renown Medical Group - Oncology/Hematology /ID# 247942 — Reno, Nevada (2.3 mi)
· Sponsor: AbbVie
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
Renown Regional Medical Center ( Site 0041) — Reno, Nevada (2.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
Diabetic Retinopathy
Phase 2, Phase 3
Interventional 576 participants sought
Sierra Eye Associates /ID# 274737 — Reno, Nevada (2.3 mi)
· Sponsor: AbbVie
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi)
· Sponsor: SWOG Cancer Research Network
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer
Phase 3
Interventional 186 participants sought
Center of Hope — Reno, Nevada (2.3 mi)
· Sponsor: Genelux Corporation
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8
Phase 2
Interventional 146 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Metastatic Breast Cancer
Phase 3
Interventional 600 participants sought
Renown Regional Medical Centre — Reno, Nevada (2.3 mi)
· Sponsor: LeonaBio
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
Breast Cancer, TNBC - Triple-Negative Breast Cancer
N/A
Observational 900 participants sought
Cancer Care Specialist of Reno — Reno, Nevada (2.3 mi)
· Sponsor: Tempus AI
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Retroperitoneal Sarcoma, Liposarcoma
Phase 3
Interventional 250 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi)
· Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
B Acute Lymphoblastic Leukemia Associated With Down Syndrome, Down Syndrome
N/A
Observational 330 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi)
· Sponsor: Children's Oncology Group
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi)
· Sponsor: NRG Oncology
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi)
· Sponsor: NRG Oncology
Phase 2 Trial of RGX-314 in Adults With Center Involved - Diabetic Macular Edema (CI - DME)
Diabetic Macular Edema
Phase 2
Interventional 18 participants sought
Sierra Eye Associates — Reno, Nevada (2.3 mi)
· Sponsor: Sierra Eye Associates
The Impact of Enhanced Music & Natural Visuals on Emotional Health
Emotion Management Skills, Lifestyle, Healthy
N/A
Interventional 200 participants sought
Reno Running Company — Reno, Nevada (2.3 mi)
· Sponsor: soundBrilliance LLC
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
Glioblastoma
Phase 3
Interventional 741 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi)
· Sponsor: NovoCure GmbH
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Carson City, Nevada (27.0 mi)
· Sponsor: AstraZeneca
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi)
· Sponsor: SWOG Cancer Research Network
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Reno, Nevada (2.3 mi)
· Sponsor: Akero Therapeutics, Inc
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
Acute Respiratory Distress Syndrome (ARDS), ARDS
Phase 2
Interventional 200 participants sought
Renown Institute for Heart & Vascular Health — Reno, Nevada (2.3 mi)
· Sponsor: PPD Development, LP
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Pancreatic Carcinoma, Pancreatic Neoplasm
Phase 3
Interventional 274 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Metastatic Breast Cancer
Phase 3
Interventional 230 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi)
· Sponsor: Hoffmann-La Roche
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic
Phase 3
Interventional 735 participants sought
Renown Regional Medical Center-Renown Health Medical Oncology ( Site 5434) — Reno, Nevada (2.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Liver Neoplasms, Primary Liver Cancer
N/A
Observational 5,000 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi)
· Sponsor: HistoSonics, Inc.
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Intestinal Neoplasms, Gastrointestinal Neoplasms
Phase 3
Interventional 800 participants sought
Renown Health Medical Oncology — Reno, Nevada (2.3 mi)
· Sponsor: Pfizer
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia
Phase 3
Interventional 303 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology